Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 3,173 | 4,471 | 0 | 0 |
| Operating Income | -3,173 | -4,471 | N/A | N/A |
| Interest Expense | 197 | 251 | 0 | 0 |
| Other Income | 134 | 0 | 0 | 0 |
| Pre-tax Income | -3,237 | -4,721 | 0 | 0 |
| Net Income Continuous | -3,237 | -4,721 | N/A | N/A |
| Net Income | $-3,237 | $-4,721 | $N/A | $N/A |
| EPS Basic Total Ops | -4,053.97 | -5,925.04 | N/A | N/A |
| EPS Basic Continuous Ops | -4,062.67 | -5,926.50 | N/A | N/A |
| EPS Diluted Total Ops | -4,053.97 | -5,925.04 | N/A | N/A |
| EPS Diluted Continuous Ops | -4,062.67 | -5,926.50 | N/A | N/A |
| EBITDA(a) | $-3,075 | $-4,328 | $N/A | $N/A |